tiprankstipranks
Trending News
More News >
Epigenomics (DE:ECX)
FRANKFURT:ECX
Germany Market

Epigenomics (ECX) Financial Statements

Compare
1 Followers

Epigenomics Financial Overview

Epigenomics's market cap is currently €789.25K. The company's EPS TTM is €-0.233; its P/E ratio is -0.29; Epigenomics is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 339.00K€ 485.00K€ 6.20M
Gross Profit€ 282.00K€ 365.00K€ 6.07M
Operating Income€ -4.18M€ -12.05M€ -2.35M
EBITDA€ -2.83M€ -11.22M€ -1.94M
Net Income€ -4.46M€ -12.02M€ -2.43M
Balance Sheet
Cash & Short-Term Investments€ 2.10M€ 10.04M€ 23.05M
Total Assets€ 12.85M€ 15.85M€ 24.66M
Total Debt€ 11.89M€ 841.00K€ 460.00K
Net Debt€ 9.79M€ -9.20M€ -22.59M
Total Liabilities€ 12.85M€ 5.68M€ 2.54M
Stockholders' Equity€ 0.00€ 10.17M€ 22.12M
Cash Flow
Free Cash Flow€ -5.71M€ -13.39M€ -4.19M
Operating Cash Flow€ -5.71M€ -12.02M€ -4.15M
Investing Cash Flow€ 68.00K€ -1.70M€ 961.00K
Financing Cash Flow€ -57.00K€ -359.00K€ 21.62M
Currency in EUR

Epigenomics Earnings and Revenue History

Epigenomics Debt to Assets

Epigenomics Cash Flow

Epigenomics Forecast EPS vs Actual EPS